Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
704 (USA) · Dr. Tanaka
consented 2013-10-24
Adverse events
Mild ABDOMINAL DISCOMFORT — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-26 (study day 3.0); relationship: REMOTE
Mild APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-09 (study day 17.0); relationship: PROBABLE
Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-27 (study day 4.0); relationship: PROBABLE
Mild CHILLS — outcome: RECOVERED/RESOLVED; onset 2013-11-17 (study day 25.0); relationship: REMOTE
Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2013-12-15 (study day 53.0); relationship: REMOTE
Mild DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-11-17 (study day 25.0); relationship: REMOTE
Mild HYPERHIDROSIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-09 (study day 17.0); relationship: POSSIBLE
Mild MALAISE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-09 (study day 17.0); relationship: POSSIBLE
Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-27 (study day 4.0); relationship: PROBABLE
Mild SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-24 (study day 62.0); relationship: NONE
Data queries
No data queries.